Clinical Trial Update: Honokiol in Early-Stage Resectable Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating honokiol in early-stage resectable non-small cell lung cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Honokiol (Honokiol)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Carcinoma, Non-Small-Cell Lung | Phase 1 | Status: RECRUITING